Registrati | Log in | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

di jyuh arb [90 articles]

Articoli aggiunti di recente alla biblioteca di jyuh classificati sotto il tag arb. You can also see everyone's arb.
  • Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increase.
    Proceedings of the National Academy of Sciences of the United States of America (6 October 2008)
    by Zhongyi Zhang, Yan Zhang, Gang Ning, Dilip K K Deb, Juan Kong, Yan Chun C Li
    posted to vitamin-d stz mouse dn arb by jyuh on 2008-10-08 15:43:38 as **
  • Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials.
    American heart journal, Vol. 148, No. 1. (July 2004), pp. 52-61.
    by K Teo, S Yusuf, P Sleight, C Anderson, F Mookadam, B Ramos, L Hilbrich, J Pogue, H Schumacher,
    posted to rct cv arb aceiarb acei by jyuh on 2008-10-07 09:39:52 as **
  • Effect of angiotensin II and angiotensin II type 1 receptor antagonist on the proliferation, contraction and collagen synthesis in rat hepatic stellate cells.
    Chinese medical journal, Vol. 121, No. 2. (20 January 2008), pp. 161-165.
    by J Liu, H Gong, ZT Zhang, Y Wang
    posted to hsc collagen arb aii by jyuh on 2008-10-04 04:48:02 as **
  • Inhibition of renin angiotensin system decreases renal protein oxidative damage in diabetic rats.
    Biochemical and biophysical research communications, Vol. 368, No. 3. (11 April 2008), pp. 528-535.
    by M Portero-Otín, R Pamplona, J Boada, M Jové, H Gonzalo, M Buleon, W Linz, S Schäfer, I Tack, JP Girolami
    posted to ros dn arb aii acei by jyuh on 2008-10-04 02:35:29 as **
  • Effect of losartan on cyclooxygenase-2 expression in normal human mesangial cells and kidneys of rats with diabetic nephropathy.
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, Vol. 33, No. 9. (September 2008), pp. 790-799.
    by QL Zhou, WS Peng, Y Yuichiro, ZC Liu, JH Yang
    posted to stz rat mesangial hg dn cox2 arb by jyuh on 2008-10-04 02:25:06 as **
  • Effect of Renin-Angiotensin-Aldosterone System Inhibition, Dietary Sodium Restriction, and/or Diuretics on Urinary Kidney Injury Molecule 1 Excretion in Nondiabetic Proteinuric Kidney Disease: A Post Hoc Analysis of a Randomized Controlled Trial.
    American journal of kidney diseases : the official journal of the National Kidney Foundation (25 September 2008)
    by Femke Waanders, Vishal S S Vaidya, Harry van V Goor, Henri Leuvenink, Kevin Damman, Inge Hamming, Joseph V V Bonventre, Liffert Vogt, Gerjan Navis
    posted to urine salt rct nondn kim1 diuretics arb acei by jyuh on 2008-10-03 04:06:01 as **
  • Irbesartan treatment of patients with type 2 diabetes, hypertension and renal disease: a UK health economics analysis
    International Journal of Clinical Practice, Vol. 61, No. 10. (October 2007), pp. 1626-1633.
    by Palmer, , Valentine, , Ray,
    posted to dm cea arb by jyuh on 2008-10-03 03:04:29 as **
  • Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus.
    Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease, Vol. 5, No. 1. (March 2008), pp. 59-66.
    by DK McGuire, JR Winterfield, JA Rytlewski, E Ferrannini
    posted to prevention dm arb acei by jyuh on 2008-10-02 16:33:23 as **
  • Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial.
    Lancet, Vol. 369, No. 9579. (23 June 2007), pp. 2079-2087.
    by SD Solomon, R Janardhanan, A Verma, M Bourgoun, WL Daley, D Purkayastha, Y Lacourcière, SE Hippler, H Fields, TZ Naqvi, SL Mulvagh, JM Arnold, JD Thomas, MR Zile, GP Aurigemma,
    posted to chf bp arb by jyuh on 2008-10-02 11:00:02 as **
  • Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials.
    BMJ (Clinical research ed.), Vol. 334, No. 7597. (14 April 2007)
    by I Ferreira-González, JW Busse, D Heels-Ansdell, VM Montori, EA Akl, DM Bryant, P Alonso-Coello, J Alonso, A Worster, S Upadhye, R Jaeschke, HJ Schünemann, G Permanyer-Miralda, V Pacheco-Huergo, A Domingo-Salvany, P Wu, EJ Mills, GH Guyatt
    posted to rct multiplicity creatinine arb by jyuh on 2008-10-01 16:17:44 as **
  • The role of renin-angiotensin-aldosterone system-based therapy in diabetes prevention and cardiovascular and renal protection.
    Diabetes, obesity & metabolism (20 May 2008)
    by Hussam Abuissa, James O'Keefe
    posted to dm cv ckd arb acei by jyuh on 2008-10-01 03:27:12 as **
  • Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials
    Diabetes, Obesity and Metabolism, Vol. 10, No. 1. (January 2008), pp. 41-52.
    by Saha, , Molnar, , Arora,
    posted to rct meta-analysis dm cv arb acei by jyuh on 2008-09-25 10:02:11 as **
  • Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.
    Lancet neurology (29 August 2008)
    by Hans-Christoph C Diener, Ralph L L Sacco, Salim Yusuf, Daniel Cotton, Stephanie Ounpuu, William A A Lawton, Yuko Palesch, Reneé H H Martin, Gregory W W Albers, Philip Bath, Natan Bornstein, Bernard Pl P Chan, Sien-Tsong T Chen, Luis Cunha, Björn Dahlöf, Jacques De Keyser, Geoffrey A A Donnan, Conrado Estol, Philip Gorelick, Vivian Gu, Karin Hermansson, Lutz Hilbrich, Markku Kaste, Chuanzhen Lu, Thomas Machnig, Prem Pais, Robin Roberts, Veronika Skvortsova, Philip Teal, Danilo Toni, Cam Vandermaelen, Thor Voigt, Michael Weber, Byung-Woo W Yoon,
    posted to stroke rct dipyridamole aspirin arb by jyuh on 2008-09-25 08:24:02 as ** along with 1 person Terkko
  • Angiotensin inhibition in renovascular disease: a population-based cohort study.
    American heart journal, Vol. 156, No. 3. (September 2008), pp. 549-555.
    by DG Hackam, ML Duong-Hua, M Mamdani, P Li, SW Tobe, JD Spence, AX Garg
    posted to hospitalization cv ckd arf arb acei by jyuh on 2008-09-25 08:23:02 as **
  • Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
    Lancet (29 August 2008)
    by
    posted to rct cv arb acei 1 by jyuh on 2008-09-25 08:18:17 as **
  • Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.
    Lancet, Vol. 372, No. 9638. (16 August 2008), pp. 547-553.
    by JF Mann, RE Schmieder, M McQueen, L Dyal, H Schumacher, J Pogue, X Wang, A Maggioni, A Budaj, S Chaithiraphan, K Dickstein, M Keltai, K Metsärinne, A Oto, A Parkhomenko, LS Piegas, TL Svendsen, KK Teo, S Yusuf,
    posted to rct dn cv arb aceiarb acei 1 by jyuh on 2008-09-25 08:05:33 as ** along with 1 person blr251
  • Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events.
    The New England journal of medicine (27 August 2008)
    by Salim Yusuf, Hans-Christoph C Diener, Ralph L L Sacco, Daniel Cotton, Stephanie Ounpuu, William A A Lawton, Yuko Palesch, Reneé H H Martin, Gregory W W Albers, Philip Bath, Natan Bornstein, Bernard P L P Chan, Sien-Tsong T Chen, Luis Cunha, Björn Dahlöf, Jacques De Keyser, Geoffrey A A Donnan, Conrado Estol, Philip Gorelick, Vivian Gu, Karin Hermansson, Lutz Hilbrich, Markku Kaste, Chuanzhen Lu, Thomas Machnig, Prem Pais, Robin Roberts, Veronika Skvortsova, Philip Teal, Danilo Toni, Cam Vandermaelen, Thor Voigt, Michael Weber, Byung-Woo W Yoon,
    posted to stroke rct cv arb by jyuh on 2008-09-25 08:00:18 as ** along with 2 people drftc Terkko
  • Are two better than one? Angiotensin-converting enzyme inhibitors plus angiotensin receptor blockers for reducing blood pressure and proteinuria in kidney disease.
    Clinical journal of the American Society of Nephrology : CJASN, Vol. 3 Suppl 1 (January 2008)
    by SL Linas
    posted to ckd arb aceiarb acei by jyuh on 2008-09-13 09:13:12 as **
  • Angiotensin receptor blockers: RAAS blockade and renoprotection
    Current Medical Research and Opinion, Vol. 24, No. 5. (May 2008), pp. 1285-1293.
    by Ruilope, M Luis
    posted to ckd arb acei by jyuh on 2008-09-13 08:38:15 as **
  • Expression of NG,NG-dimethylarginine dimethylaminohydrolase and protein arginine N-methyltransferase isoforms in diabetic rat kidney: effects of angiotensin II receptor blockers.
    Diabetes, Vol. 57, No. 1. (January 2008), pp. 172-180.
    by ML Onozato, A Tojo, J Leiper, T Fujita, F Palm, CS Wilcox
    posted to stz rat dn arb adma by jyuh on 2008-09-11 16:44:11 as **
  • Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy.
    Diabetes care, Vol. 28, No. 7. (July 2005), pp. 1690-1697.
    by F Chiarelli, D Di Marzio, F Santilli, A Mohn, A Blasetti, F Cipollone, A Mezzetti, A Verrotti
    posted to ros fibroblast dn arb by jyuh on 2008-09-09 05:33:10 as **
  • Combination therapy with renin-angiotensin system inhibitors and the calcium channel blocker azelnidipine decreases plasma inflammatory markers and urinary oxidative stress markers in patients with diabetic nephropathy.
    Hypertension research : official journal of the Japanese Society of Hypertension, Vol. 31, No. 6. (June 2008), pp. 1147-1155.
    by S Ogawa, T Mori, K Nako, S Ito
    posted to dn ccb arb acei by jyuh on 2008-09-07 06:06:49 as **
  • Reduction of albuminuria by angiotensin receptor blocker beyond blood pressure lowering: Evaluation in megsin/receptor for advanced glycation end products/inducible nitric oxide synthase triple transgenic diabetic nephropathy mouse model.
    Nephrology (Carlton, Vic.) (17 March 2008)
    by Shuichi Ohtomo, Masaki Ito, Yuko Izuhara, Charles van Ypersele de Strihou, Toshio Miyata
    posted to arb dn mouse by jyuh on 2008-08-30 06:38:40 as **
  • Uricosuric Action of Losartan via the Inhibition of Urate Transporter 1 (URAT 1) in Hypertensive Patients.
    American journal of hypertension : journal of the American Society of Hypertension (31 July 2008)
    by Toshihiro Hamada, Kimiyoshi Ichida, Makoto Hosoyamada, Einosuke Mizuta, Kiyotaka Yanagihara, Kazuhiko Sonoyama, Shinobu Sugihara, Osamu Igawa, Tatsuo Hosoya, Akira Ohtahara, Chiaki Shigamasa, Yasutaka Yamamoto, Haruaki Ninomiya, Ichiro Hisatome
    posted to ua arb bp urate-transporter by jyuh on 2008-08-12 04:49:36 as **
  • Effect of Angiotensin Receptor Blockers on Cardiovascular Events in Patients Undergoing Hemodialysis: An Open-Label Randomized Controlled Trial.
    American journal of kidney diseases : the official journal of the National Kidney Foundation (22 July 2008)
    by Hiromichi Suzuki, Yoshihiko Kanno, Soichi Sugahara, Naofumi Ikeda, Junko Shoda, Tsuneo Takenaka, Tsutomu Inoue, Ryuichiro Araki
    posted to arb cv hd rct by jyuh on 2008-08-06 09:19:29 as **
  • Angiotensin Receptor Blockers: Current Status and Future Prospects
    The American Journal of Medicine, Vol. 121, No. 8. (August 2008), pp. 656-663.
    by Ram
    posted to arb rct by jyuh on 2008-08-06 08:42:27 as **
  • Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, Vol. 9, No. 1. (March 2008), pp. 1-9.
    by B Gojanovic, F Feihl, L Liaudet, B Waeber
    posted to acei arb bp ccb by jyuh on 2008-07-21 05:49:29 as **
  • Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors: where do we stand now?
    The American journal of cardiology, Vol. 100, No. 3A. (6 August 2007)
    by M Böhm
    posted to aceiarb acei arb cv rct by jyuh on 2008-07-21 05:03:00 as **
  • The COOPERATE trial: a letter of concern.
    Lancet, Vol. 371, No. 9624. (10 May 2008), pp. 1575-1576.
    by R Kunz, M Wolbers, T Glass, JF Mann
    posted to acei arb meta-analysis rct by jyuh on 2008-07-21 05:00:41 as **
  • Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial.
    Lancet, Vol. 361, No. 9352. (11 January 2003), pp. 117-124.
    by N Nakao, A Yoshimura, H Morita, M Takada, T Kayano, T Ideura
    posted to aceiarb acei arb ckd rct by jyuh on 2008-07-21 04:47:08 as **
  • Sex differences in response to chronic heart failure therapies
    Expert Review of Cardiovascular Therapy, Vol. 6, No. 4. (April 2008), pp. 555-565.
    by Ghali, K Jalal, Lindenfeld, Joann
    posted to acei arb chf gender by jyuh on 2008-07-21 04:39:52 as **
  • Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) and resource utilization and costs in Italy.
    Vascular health and risk management, Vol. 4, No. 1. (2008), pp. 223-234.
    by GL Colombo, M Caruggi, C Ottolini, AP Maggioni
    posted to cea aceiarb acei arb rct by jyuh on 2008-07-21 04:19:24 as **
  • Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
    European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology, Vol. 10, No. 2. (February 2008), pp. 157-163.
    by RA Weir, JJ McMurray, M Puu, SD Solomon, B Olofsson, CB Granger, S Yusuf, EL Michelson, K Swedberg, MA Pfeffer,
    posted to aceiarb acei arb chf rct by jyuh on 2008-07-21 04:10:12 as **
  • Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
    Circulation, Vol. 115, No. 24. (19 June 2007), pp. 3111-3120.
    by E O'Meara, T Clayton, MB McEntegart, JJ McMurray, IL Piña, CB Granger, J Ostergren, EL Michelson, SD Solomon, S Pocock, S Yusuf, K Swedberg, MA Pfeffer,
    posted to arb chf gender rct by jyuh on 2008-07-21 04:09:11 as **
  • Angiotensin II receptor blockers for the treatment of heart failure: a class effect?
    Pharmacotherapy, Vol. 27, No. 4. (April 2007), pp. 526-534.
    by M Hudson, K Humphries, JV Tu, H Behlouli, R Sheppard, L Pilote
    posted to arb chf by jyuh on 2008-07-21 03:14:42 as **
  • Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure--a population study.
    European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology, Vol. 9, No. 6-7. (l 2007), pp. 602-609.
    by M Hudson, E Rahme, H Behlouli, R Sheppard, L Pilote
    posted to acei arb chf gender by jyuh on 2008-07-21 03:13:15 as **
  • Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system.
    Journal of hypertension, Vol. 25, No. 5. (May 2007), pp. 951-958.
    by , F Turnbull, B Neal, M Pfeffer, J Kostis, C Algert, M Woodward, J Chalmers, A Zanchetti, S MacMahon
    posted to rct cv bp arb acei by jyuh on 2008-07-21 02:08:23 as **
  • Targeting cardiovascular protection: the concept of dual renin-angiotensin system control.
    Medscape journal of medicine, Vol. 10 Suppl (2008)
    by T Unger, A Jakobsen, J Heroys, A Ralph, T Rees, M Shaw
    posted to aceiarb acei arb by jyuh on 2008-07-21 02:01:04 as **
  • No HOPE without proof: do ARBs meet the standard for cardiovascular protection?
    Medscape journal of medicine, Vol. 10 Suppl (2008)
    by P Sleight, A Jakobsen, J Heroys, A Ralph, T Rees, M Shaw
    posted to rct meta-analysis cv arb acei by jyuh on 2008-07-21 02:00:45 as **
  • Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
    Journal of hypertension, Vol. 26, No. 7. (July 2008), pp. 1282-1289.
    by Gianpaolo Reboldi, Fabio Angeli, Claudio Cavallini, Giorgio Gentile, Giuseppe Mancia, Paolo Verdecchia
    posted to acei arb cv meta-analysis mortality stroke by jyuh on 2008-07-21 01:49:35 as **
  • Partial Peroxisome Proliferator-Activated Receptor Agonist Angiotensin Receptor Blockers. Potential Multipronged Strategy in Stroke Prevention.
    Cerebrovascular diseases (Basel, Switzerland), Vol. 26, No. 2. (17 June 2008), pp. 106-112.
    by Amytis Towfighi, Bruce Ovbiagele
    posted to arb ppar stroke by jyuh on 2008-07-21 01:47:26 as **
  • Reduction of proteinuria with angiotensin receptor blockers.
    Nature clinical practice. Cardiovascular medicine, Vol. 5 Suppl 1 (July 2008)
    by J Galle
    posted to arb proteinuria by jyuh on 2008-07-20 16:00:45 as **
  • Reporting on sex-based analysis in clinical trials of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker efficacy.
    The Canadian journal of cardiology, Vol. 24, No. 6. (June 2008), pp. 491-496.
    by DM Rabi, N Khan, M Vallee, MA Hladunewich, SW Tobe, L Pilote
    posted to acei arb gender rct by jyuh on 2008-07-20 15:56:27 as **
  • RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection.
    Clinical research in cardiology : official journal of the German Cardiac Society, Vol. 97, No. 7. (July 2008), pp. 418-431.
    by C Werner, M Baumhäkel, KK Teo, R Schmieder, J Mann, T Unger, S Yusuf, M Böhm
    posted to aceiarb acei arb by jyuh on 2008-07-20 15:55:07 as **
  • Comparison of dual RAAS blockade and higher-dose RAAS inhibition on nephropathy progression.
    Postgraduate medicine, Vol. 120, No. 1. (April 2008), pp. 33-42.
    by GL Bakris, MR Weir
    posted to aceiarb acei arb ckd by jyuh on 2008-07-20 15:17:06 as **
  • Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials.
    Journal of cardiac failure, Vol. 14, No. 3. (April 2008), pp. 181-188.
    by R Lakhdar, MH Al-Mallah, DE Lanfear
    posted to aceiarb acei arb cv meta-analysis by jyuh on 2008-07-20 15:06:28 as **
  • Maximising antihypertensive effects of angiotensin II receptor blockers with thiazide diuretic combination therapy: focus on irbesartan/hydrochlorothiazide
    International Journal of Clinical Practice, Vol. 61, No. 12. (December 2007), pp. 2093-2102.
    by Flack,
    posted to arb diuretics by jyuh on 2008-07-20 02:08:59 as **
  • Olmesartan medoxomil : a review of its use in the management of hypertension.
    Drugs, Vol. 68, No. 9. (2008), pp. 1239-1272.
    by LJ Scott, PL McCormack
    posted to arb by jyuh on 2008-07-19 16:59:24 as **
  • Comparison of Angiotensin II Type 1 Receptor Antagonists in the Treatment of Essential Hypertension.
    Drugs, Vol. 68, No. 9. (2008), pp. 1207-1225.
    by DH Smith
    posted to arb ht by jyuh on 2008-07-19 16:52:27 as **
  • Irbesartan : a review of its use in hypertension and diabetic nephropathy.
    Drugs, Vol. 68, No. 11. (2008), pp. 1543-1569.
    by KF Croom, GL Plosker
    posted to arb dn rct by jyuh on 2008-07-19 16:47:50 as **
    • Puoi citare questa pagina come: http://www.citeulike.org/user/jyuh/tag/arb

    Result page: 1 2 Next RIS BibTeX